TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: f5eb92aab5b3b1f23495b4984fb98e71d1e48224
First added on: Mar 18, 2025